Femoxetine hydrochloride

CAS No. 56222-04-9

Femoxetine hydrochloride( —— )

Catalog No. M36272 CAS No. 56222-04-9

Femoxetine hydrochloride is a selective 5-hydroxytryptamine reuptake inhibitor used in the study of migraine, depression and eating disorders.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 319 Get Quote
5MG 504 Get Quote
10MG 728 Get Quote
25MG 1086 Get Quote
50MG 1463 Get Quote
100MG 1935 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Femoxetine hydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    Femoxetine hydrochloride is a selective 5-hydroxytryptamine reuptake inhibitor used in the study of migraine, depression and eating disorders.
  • Description
    Femoxetine hydrochloride is a selective 5-hydroxytryptamine reuptake inhibitor used in the study of migraine, depression and eating disorders.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    5-HT Receptor
  • Recptor
    5-HT Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    56222-04-9
  • Formula Weight
    347.88
  • Molecular Formula
    C20H26ClNO2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(OC1=CC=C(OC)C=C1)[C@@H]2[C@H](CCN(C)C2)C3=CC=CC=C3.Cl
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Risperidone hydrochl...

    An antipsychotic agent with serotonin-S2 and dopamine-D2 antagonistic properties.

  • Binospirone

    Binospirone (MDL 73005EF) is a 5-HT1A receptor agonist with anxiolytic activity used in the study of glaucoma and movement disorders associated with neurologic dysfunction.

  • (4E)-SUN9221

    (4E)-SUN9221 is a potent dual α1-adrenergic receptor and 5-HT2 receptor antagonist, exhibiting antihypertensive and antiplatelet aggregation activities in hypertensive rats.